Clinical Trial Update: A Study of KW-0761 in Subjects With HTLV-1 Associated Myelopathy (HAM) [Phase 3]

View source ↗

Summary

Phase 3 trial of KW-0761 for HTLV-1 Associated Myelopathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Htlv-1-associated Myelopathy

Drugs mentioned

• KW-0761 (mogamulizumab)

Snippet

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: HTLV-1 Associated Myelopathy | Phase 3 | Status: TERMINATED